Table 3.
Association between psoriasis severity and metabolic syndrome and its components adjusted on age and sex
| Abdominal obesity OR (95% CI) |
Raised triglyceride levels OR (95% CI) |
Low HDL-C OR (95% CI) |
High blood pressure OR (95% CI) |
Hyperglycemia OR (95% CI) |
Metabolic Syndrome OR (95% CI) |
|
|---|---|---|---|---|---|---|
| No psoriasis, n=163 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Psoriasis overall, n=244 By extent |
2.29 (1.39-3.78) | 1.42 (0.87-1.04) | 1.87 (1.18-2.96) | 3.81 (2.30-6.31) | 1.92 (1.08-3.41) | 2.66 (1.58-4.42) |
| Mild psoriasis (PASI <10), n=75 |
1.92 (1.02-3.63) | 1.44 (0.78-2.68) | 1.34 (0.74-2.43) | 4.24 (2.17-8.32) | 1.40 (0.66-2.96) | 2.28 (1.19-4.35) |
| Moderate psoriasis (PASI: 10–20), n=84 |
2.53 (1.36-4.71) | 1.75 (0.96-3.19) | 1.88 (1.05-3.37) | 4.45 (2.29-8.63) | 1.70 (0.84-3.43) | 3.21 (1.72-6.02) |
| Severe psoriasis (PASI ≥20), n=85 |
2.48 (1.32-4.68) | 1.10 (0.59-2.06) | 2.63 (1.45-4.77) | 2.93 (1.54-5.61) | 2.80 (1.41-5.54) | 2.46 (1.29-4.66) |